BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cao J, Kong FH, Liu X, Wang XB. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2019; 25(27): 3649-3663 [PMID: 31367163 DOI: 10.3748/wjg.v25.i27.3649]
URL: https://www.wjgnet.com/2218-6190/full/v25/i27/3649.htm
Number Citing Articles
1
Danijel Galun, Dragana Mijac, Aleksandar Filipovic, Aleksandar Bogdanovic, Marko Zivanovic, Dragan Masulovic. Precision Medicine for Hepatocellular Carcinoma: Clinical PerspectiveJournal of Personalized Medicine 2022; 12(2): 149 doi: 10.3390/jpm12020149
2
Rachel M. Golonka, Matam Vijay-Kumar. Mechanisms and Therapy of Liver CancerAdvances in Cancer Research 2021; 149: 171 doi: 10.1016/bs.acr.2020.10.004
3
Gbemisola Lawal, Yao Xiao, Amir A. Rahnemai-Azar, Diamantis I. Tsilimigras, Ming Kuang, Anargyros Bakopoulos, Timothy M. Pawlik. The Immunology of Hepatocellular CarcinomaVaccines 2021; 9(10): 1184 doi: 10.3390/vaccines9101184
4
Linh Pham, Konstantina Kyritsi, Tianhao Zhou, Ludovica Ceci, Leonardo Baiocchi, Lindsey Kennedy, Sanjukta Chakraborty, Shannon Glaser, Heather Francis, Gianfranco Alpini, Keisaku Sato. The Functional Roles of Immune Cells in Primary Liver CancerThe American Journal of Pathology 2022;  doi: 10.1016/j.ajpath.2022.02.004
5
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, Craig McFarlane, Lionel Hebbard. Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic dataSeminars in Cancer Biology 2022;  doi: 10.1016/j.semcancer.2022.01.005
6
Yuting Qiu, Haobo Li, Jiaheng Xie, Xinwei Qiao, Jing Wu. Identification of ABCC5 Among ATP-Binding Cassette Transporter Family as a New Biomarker for Hepatocellular Carcinoma Based on Bioinformatics AnalysisInternational Journal of General Medicine 2021; : 7235 doi: 10.2147/IJGM.S333904
7
Xiao-Wan Bo, Li-Ping Sun, Song-Yuan Yu, Hui-Xiong Xu. Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directionsWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1397-1411 doi: 10.4251/wjgo.v13.i10.1397
8
Justin K. H. Liu, Andrew F. Irvine, Rebecca L. Jones, Adel Samson. Immunotherapies for hepatocellular carcinomaCancer Medicine 2022; 11(3): 571 doi: 10.1002/cam4.4468
9
Zuzanna Sas, Ewa Cendrowicz, Isabel Weinhäuser, Tomasz P. Rygiel. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment OptionsInternational Journal of Molecular Sciences 2022; 23(7): 3778 doi: 10.3390/ijms23073778
10
Xiongpei Huang, Zecheng Qiu, Liusheng Li, Bin Chen, Peiyuan Huang. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinomaAging 2021; 13(16): 20698 doi: 10.18632/aging.203456
11
Shuo Wang, Xiaoli Wang, Xinna Zhou, Herbert Kim Lyerly, Michael A. Morse, Jun Ren. DC-CIK as a widely applicable cancer immunotherapyExpert Opinion on Biological Therapy 2020; 20(6): 601 doi: 10.1080/14712598.2020.1728250
12
Marcelo M. Rodríguez, Agostina Onorato, María José Cantero, Luciana Domínguez, Juan Bayo, Esteban Fiore, Mariana García, Catalina Atorrasagasti, Ali Canbay, Mariana Malvicini, Guillermo D. Mazzolini. 4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in miceScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85491-0
13
Harriet Roddy, Tim Meyer, Claire Roddie. Novel Cellular Therapies for Hepatocellular CarcinomaCancers 2022; 14(3): 504 doi: 10.3390/cancers14030504
14
Qiu-Zhong Pan, Qing Liu, Yu-Qing Zhou, Jing-Jing Zhao, Qi-Jing Wang, Yong-Qiang Li, Yan Tang, Jia-Mei Gu, Jia He, Shi-Ping Chen, De-Sheng Weng, Jian-Chuan Xia. CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinomaCancer Immunology, Immunotherapy 2020; 69(5): 825 doi: 10.1007/s00262-020-02486-y
15
Guodai Hong, Silun Xie, Zikuan Guo, Diping Zhang, Sihai Ge, Suqin Zhang, Wenbin Gao. Progression-Free Survival of a Patient with Advanced Hepatocellular Carcinoma Treated with Adoptive Cell Therapy Using Natural Killer Cells: A Case ReportOncoTargets and Therapy 2022; : 255 doi: 10.2147/OTT.S344707
16
Harry Cheuk Hay Lau, Joseph Jao-Yiu Sung, Jun Yu. Gut microbiota: impacts on gastrointestinal cancer immunotherapyGut Microbes 2021; 13(1) doi: 10.1080/19490976.2020.1869504
17
Haipeng Zhu, Xiaojun Liu. Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal MalignanciesFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.666340
18
Tong Wu, Linzhi Zhang, Zhen Zeng, Tao Yan, Jiamin Cheng, Xiaojie Miao, Yinying Lu. Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment: A Report of Two CasesOncoTargets and Therapy 2021; : 5447 doi: 10.2147/OTT.S333604
19
Eleni-Myrto Trifylli, Evangelos Koustas, Nikolaos Papadopoulos, Panagiotis Sarantis, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Michalis V. Karamouzis. An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and CholangiocarcinomaLife 2022; 12(5): 665 doi: 10.3390/life12050665
20
He Huang, Shilei Xu, Aidong Chen, Fen Li, Jiezhong Wu, Xusheng Tu, Kunpeng Hu, Makoto Endo. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer PatientsAnalytical Cellular Pathology 2021; 2021: 1 doi: 10.1155/2021/6697407
21
Konstantinos Damiris, Hamza Abbad, Nikolaos Pyrsopoulos. Cellular based treatment modalities for unresectable hepatocellular carcinomaWorld Journal of Clinical Oncology 2021; 12(5): 290-308 doi: 10.5306/wjco.v12.i5.290
22
Li Zhang, Jia Ding, Hui-Yan Li, Zhong-Hua Wang, Jian Wu. Immunotherapy for advanced hepatocellular carcinoma, where are we?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188441 doi: 10.1016/j.bbcan.2020.188441